Fundraising Fox

Onconova Therapeutics

NASDAQ: TRAW

Newtown, US · Founded 1998 · Delaware corporation · 19 employees on LinkedIn · 1 known investors

Biotech

Founders & leadership

Onconova Therapeutics was founded in 1998 by Ramesh Kumar, Ph.D and E. Premkumar Reddy.

RK
Ramesh Kumar, Ph.DCo-founder
EP
E. Premkumar ReddyCo-founder
MM
Manoj ManiarinExecutive
TM
Thomas McKearnExecutive
ABAjay Bansal
Ajay BansalinCFO2013–2016
SFSteven Fruchtman
Steven FruchtmaninPresident and CEO2019–2024

Board

MH
Michael HoffmanBoard director
VM
Viren MehtaBoard director
AM
Anne M. VanLentBoard director
HS
Henry S BienenBoard director
JM
James MarinoBoard director
JE
Jerome E. GroopmanBoard director

Investors · 1

OrbiMedreportedNew York · $1M – $75M

Reported raises · per SEC filings

Form D private placements

$17.3M disclosed across 4 of 5 rounds · 2015–2024

▶$14MraisedApr 2024 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • M. Theresa ShoemakerDirector
  • Jack E. StoverDirector
  • Trafford ClarkeDirector
  • Nikolay SavchukDirector, Executive Officer
  • Ian DukesDirector
  • David PauzaExecutive Officer
  • Robert RedfieldExecutive Officer
  • Mark GuerinExecutive Officer
  • Steven FruchtmanExecutive Officer
  • Werner CautreelsDirector, Executive Officer
  • James MarinoDirector
Offering amount
$14M
Amount sold
$14M
Sales commissions
$1M
First sale
Apr 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedJun 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael B. HoffmanDirector
  • Jerome E. GroopmanDirector
  • Abraham N. OlerExecutive Officer
  • Viren MehtaDirector
  • James J. MarinoDirector
  • Premkumar ReddyDirector
  • Jack E. StoverDirector
  • Steven M. FruchtmanExecutive Officer, Director
  • Manoj ManiarExecutive Officer
  • Mark P. GuerinExecutive Officer
  • Richard C. WoodmanExecutive Officer
Offering amount
$2M
Amount sold
$500K
Minimum investment
$500K
First sale
May 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedJun 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael B. HoffmanDirector
  • Jerome E. GroopmanDirector
  • Mark P. GuerinExecutive Officer
  • Jack E. StoverDirector
  • Ramesh KumarExecutive Officer, Director
  • Manoj ManiarExecutive Officer
  • E. Premkumar ReddyDirector
  • Steven M. FruchtmanExecutive Officer
  • Henry S. BienenDirector
  • James J. MarinoDirector
  • Viren MehtaDirector
Offering amount
$1.3M
Amount sold
$1.3M
Minimum investment
$1.3M
Sales commissions
$75K
Placement agents
Lucas Advisors LLC d/b/a KYBORA Emerging Markets
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedOct 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Manoj ManiarExecutive Officer
  • Thomas McKearnExecutive Officer
  • Ajay BansalExecutive Officer
  • Anne M. VanLentDirector
  • Henry S BienenDirector
  • Ramesh Kumar, Ph.DExecutive Officer, Director
  • E. Premkumar ReddyDirector
  • James MarinoDirector
  • Jerome E. GroopmanDirector
  • Michael HoffmanDirector
  • Viren MehtaDirector
  • Steven FruchtmanExecutive Officer
Offering amount
$16.5M
Amount sold
$1.5M
Minimum investment
$1.5M
Proceeds to insiders
$100K
First sale
Oct 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

‘Best-In-Class Virology And Oncology’: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to Form Traws Pharma, Inc.orrick.com · Apr 2024Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Companyfinance.yahoo.com · Apr 2024Onconova Therapeutics Raises $21M Via Equity At 17% Discountfinance.yahoo.com · Sep 2021Cancer Drug Developer Onconova Therapeutics Raises $77.5 Mln for IPO | PE Hubpehub.com · Jul 2013ONTX IPO News - Cancer biotech Onconova Therapeutics sets terms for $60 million IPOrenaissancecapital.com · Jul 2013Onconova Therapeutics Inc. Logs $50 Million - BioSpacebiospace.com · Aug 2012

Frequently asked questions

Who founded Onconova Therapeutics?
Onconova Therapeutics was founded by Ramesh Kumar, Ph.D, E. Premkumar Reddy in 1998.
Who are Onconova Therapeutics's investors?
Onconova Therapeutics's investors include OrbiMed.
How much funding has Onconova Therapeutics raised?
Onconova Therapeutics has disclosed $17.3M raised across 4 of its 5 known rounds.
Where is Onconova Therapeutics headquartered?
Onconova Therapeutics is headquartered in Newtown, US.